Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000;2000(4):CD000950.
doi: 10.1002/14651858.CD000950.

Carnitine supplementation of parenterally fed neonates

Affiliations
Review

Carnitine supplementation of parenterally fed neonates

P A Cairns et al. Cochrane Database Syst Rev. 2000.

Abstract

Background: Carnitine, a quaternary amino acid, plays an important role in the oxidation of long chain fatty acids. Both breast milk and infant formulas contain carnitine. However, it is not routinely provided in parenteral nutrition solutions. Non supplemented parenterally fed infants have very low tissue carnitine levels. The clinical significance of this is uncertain. Carnitine deficiency may be an etiological factor in the limited ability of premature babies to utilize parenteral lipid. In vitro studies have suggested that fatty acid oxidation is impaired when the tissue carnitine levels fall below 10% of normal. Therefore relative carnitine deficiency may impair fatty acid oxidation, thus reducing the available energy and impairing growth.

Objectives: The primary aim of this review is to determine whether carnitine supplementation of parenterally fed neonates will improve weight gain. The secondary aims are to determine the effect on lipid tolerance and ketogenesis.

Search strategy: Computerised searches were carried out by both reviewers. Searches were made of Medline, Embase, The National Research Register (UK), the Cochrane Controlled Trials Register and expert informants. The MeSH headings used were carnitine and parenteral nutrition.

Selection criteria: Only randomised trials were considered. Trials were included if they involved carnitine supplementation alone, parenterally fed newborn infants, and measured at least one outcome of interest (weight gain, plasma fatty acids, plasma triglycerides, quantity of lipid tolerated, respiratory quotient or beta hydroxybutyrate levels).

Data collection and analysis: The two reviewers searched the literature separately and reached a consensus for inclusion of trials. Data were extracted and evaluated by the two reviewers independently of each other. Authors were contacted if possible to clarify or provide missing data.

Main results: Fourteen studies were identified, six met the selection criteria. The results of the review are limited by the fact that the studies were generally short term and studied different outcomes. One study examined short term and long term weight gain, three reported only short term weight gain, three reported biochemical results in response to a short lipid challenge, and two reported results obtained during normal parenteral nutrition. Among infants supplemented with carnitine, there was no evidence of effect on weight gain, lipid utilization or ketogenesis.

Reviewer's conclusions: We found no evidence to support the routine supplementation of parenterally fed neonates with carnitine.

PubMed Disclaimer

Conflict of interest statement

None

Figures

1.1
1.1. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 1 Weight gain in first 2 weeks.
1.2
1.2. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 2 Weight gain 2‐4 weeks (g/day).
1.3
1.3. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 3 Weight gain from hospital discharge to one month post term (g/day).
1.4
1.4. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 4 Free fatty acid levels (mmol/l).
1.5
1.5. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 5 Triglyceride levels (mmol/l).
1.6
1.6. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 6 Lipid tolerance ‐ maximum amount of lipid tolerated (g/kg/day).
1.7
1.7. Analysis
Comparison 1 Carnitine supplementation vs no supplementation, Outcome 7 Ketogenesis ‐ beta hydroxybutyrate levels (mmol/l).

Similar articles

Cited by

References

References to studies included in this review

Bonner 1995a {published data only}
    1. Bonner CM, DeBrie KL, Hug G, Landrigan E, Taylor BJ. Effects of parenteral L‐carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr 1995;126:287‐92. - PubMed
Bonner 1995b {published data only}
    1. Bonner CM, Debrie Kl, Hug G, Landrigan E, Taylor BJ. Effects of parenteral L‐carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr 1995;126:287‐92. - PubMed
Coran 1985 {published data only}
    1. Coran AG, Drongowski RA, Baker PJ. The metabolic effects of oral L‐carnintine administration in infants receiving total parenteral nutrition with fat. J Pediatr Surg 1985;20:758‐764. - PubMed
Helms 1995 {published data only}
    1. Helms RA, Mauer EC, Hay WW, Christensen ML, Storm MC. Effect of intravenous L‐carnitine on growth parameters and fat metabolism during parenteral nutrition in neonates. JPEN 1990;14:448‐453. - PubMed
Larsson 1990 {published data only}
    1. Larsson LE, Olegard R, Ljung L, Niklasson A, Rubensson A, Gederblad G. Parenteral nutrition in preterm neonates with and without carnitine supplementation. Acta Anaesth Scand 1990;34:501‐05. - PubMed
Schmidt‐S. 1983a {published data only}
    1. Schmidt‐Sommerfeld E, Penn D, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L‐carnitine supplementation. J Pediatr 1983;102:931‐935. - PubMed
Schmidt‐S. 1983b {published data only}
    1. Schmidt‐Somerfeld E, Penn D, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L‐carnitine supplementation. J Pediatr 1983;102:931‐935. - PubMed
Shortland 1998 {published data only}
    1. Shortland GJ, Walter JH, Stroud C, Fleming PJ, Speidel BD, Marlow N. Randomised controlled trial of L‐carnitine as a nutritional supplement in preterm infants. Arch Dis Child 1998;78:F185‐F188. - PMC - PubMed

References to studies excluded from this review

Magnusson 1997 {published data only}
    1. Magnusson G, Boberg M, Cederblad G, Meurling S. Plasma and tissue levels of lipids, fatty acids and plasma carnitine in neonates receiving a new fat emulsion. Acta Paediatr 1997;86:638‐44. - PubMed
Melegh 1986 {published data only}
    1. Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G. Oral L‐carnitine supplementation in low birth weights: a study on neonates requiring combined parenteral and enteral nutrition. Acta Paediatr Hung 1986;27:253‐258. - PubMed
Orzali 1983 {published data only}
    1. Orzali A, Donzelli F, Enzi G, Rubaltelli F. Effect of carnitine on lipid metabolism in the newborn. Biol Neonate 1983;43:186‐190. - PubMed
Orzali 1984 {published data only}
    1. Orzali A, Maetzke G, Donzelli F, Rubaltelli F. Effect of carnitine on lipid metabolism in the neonate. II. Carnitine addition to lipid infusion during prolonged total parenteral nutrition. J Pediatr 1984;104:436‐440. - PubMed
Rubecz 1984 {published data only}
    1. Rubecz I, Sandor A, Hamar A, Mestyan J. Blood levels of carnitine and lipid utilisation with and without carnitine supplementation in newborn infants. Acta Paediatr Hung 1984;25:165‐171. - PubMed
Rubecz 1985 {published data only}
    1. Rubecz I, Sandor A, Hamar A, Vinceller M, Mestyan J. Absence of responses in energy metabolism and respiratory quotient to carnitine infusion in premature infants. Acta Paed Hung 1985;26:227‐231. - PubMed
Rubin 1995 {published data only}
    1. Rubin M, Naor N, Sirota L, Moser A, Pakula R, Harell D, Sulkes J, Davidson S, Lichtenberg D. Are bilirubin and plasma lipid profiles of premature infants dependent on the lipid emulsion infused. J Pediatr Gastroenterol Nutr 1995;21:25‐30. - PubMed
Sulkers 1990 {published data only}
    1. Sulkers EJ, Lafeber HN, Degenhart HJ, Przyrembel H, Schlotzer E, Sauer PJJ. Effects of high carnitine supplementation on substrate utilization in low‐birth‐weight infants receiving total parenteral nutrition. Am J Clin Nutr 1990;52:889‐94. - PubMed

Additional references

Borum 1983
    1. Borum PR. Carnitine. Ann Rev Nutr 1983;3:233‐259. - PubMed
Long 1982
    1. Long CS, Haller RG, Foster DW, McGarry JD. Kinetics of carnitine‐dependent fatty acid oxidation: implications for human carnitine deficiency. Neurology 1982;32:663‐6. - PubMed
Penn 1981
    1. Penn D, Schmidt‐Sommerfeld E, Pascu F. Decreased tissue carnitine concentrations in newborn infants receiving total parenteral nutrition. J Pediatr 1981;98:976‐978. - PubMed
Penn 1985
    1. Penn D, Ludwigs B, Schmidt‐Sommerfeld, Pascu F. Effect of nutrition on tissue carnitine concentrations in infants of different gestational ages. Biol Neonate 1985;47:130‐135. - PubMed
Shenai 1984
    1. Shenai JP, Borum PR. Tissue carnitine reserves of newborn infants. Ped Res 1984;18:679‐681. - PubMed